Patents Examined by Robert C. Budens
  • Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1
    Patent number: 5541104
    Abstract: The invention relates to monoclonal antibodies which specifically bind to the tumor rejection antigen precursor molecule MAGE-1, hybridomas which produce these monoclonal antibodies, and their use. Also described is a recombinant form of MAGE-1, peptides which are useful as immunogens, and immunogenic compositions containing the peptides and an adjuvant.
    Type: Grant
    Filed: February 1, 1994
    Date of Patent: July 30, 1996
    Assignees: Ludwig Institute for Cancer Research, Cornell Research Foundation, Inc.
    Inventors: Yao-Tseng Chen, Elisabeth Stockert, Yachi Chen, Pilar Garin-Chesa, Wolfgang J. Rettig, Pierre van der Bruggen, Thierry Boon-Falleur, Lloyd J. Old